CHIEFARI, EUSEBIO DOMENICO ANDREA FERNANDO
 Distribuzione geografica
Continente #
NA - Nord America 3.873
AS - Asia 2.655
EU - Europa 1.296
SA - Sud America 529
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 8.408
Nazione #
US - Stati Uniti d'America 3.743
SG - Singapore 1.259
IT - Italia 649
CN - Cina 645
BR - Brasile 405
VN - Vietnam 286
IN - India 243
DE - Germania 181
GB - Regno Unito 130
SE - Svezia 111
CA - Canada 78
FI - Finlandia 67
AR - Argentina 45
HK - Hong Kong 38
MX - Messico 30
BD - Bangladesh 28
EC - Ecuador 27
NL - Olanda 26
ID - Indonesia 21
IQ - Iraq 21
JP - Giappone 18
RU - Federazione Russa 17
PL - Polonia 16
UA - Ucraina 16
PK - Pakistan 14
EE - Estonia 12
ES - Italia 12
FR - Francia 12
CO - Colombia 11
TR - Turchia 11
AT - Austria 8
SA - Arabia Saudita 8
AZ - Azerbaigian 7
CL - Cile 7
DZ - Algeria 7
IR - Iran 7
JO - Giordania 7
MA - Marocco 7
PE - Perù 7
PY - Paraguay 7
UY - Uruguay 7
VE - Venezuela 7
JM - Giamaica 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
AU - Australia 5
BE - Belgio 5
EU - Europa 5
GH - Ghana 5
KE - Kenya 5
KR - Corea 5
RO - Romania 5
BO - Bolivia 4
IE - Irlanda 4
KZ - Kazakistan 4
NP - Nepal 4
TN - Tunisia 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
HN - Honduras 3
IL - Israele 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BG - Bulgaria 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GY - Guiana 2
LB - Libano 2
LV - Lettonia 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
SV - El Salvador 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
CG - Congo 1
CY - Cipro 1
GT - Guatemala 1
HU - Ungheria 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 8.406
Città #
San Jose 785
Dallas 457
Ashburn 391
Chandler 362
Singapore 356
Santa Clara 203
Bengaluru 181
Hefei 178
Milan 154
Lawrence 146
Princeton 146
Munich 138
Ho Chi Minh City 111
Beijing 95
Wilmington 84
London 77
Chicago 62
Council Bluffs 56
Hanoi 56
Ottawa 55
Des Moines 46
Turku 43
Los Angeles 41
Shanghai 41
Catanzaro 40
Hong Kong 37
São Paulo 33
New York 32
Boardman 31
Rome 27
Washington 27
Naples 23
Palermo 23
Helsinki 22
Tokyo 17
Guangzhou 15
Boston 14
Catania 14
Pune 14
Reggio Calabria 14
San Francisco 14
Da Nang 13
Hanover 13
Brooklyn 12
Chennai 12
Shenzhen 12
Hải Dương 11
Ninh Bình 11
Quito 11
Florence 10
Haiphong 10
Orem 10
Seattle 10
Mexico City 9
Norwalk 9
Rio de Janeiro 9
Bari 8
Campinas 8
Guayaquil 8
Manchester 8
Messina 8
Redwood City 8
San Nicola Manfredi 8
Vallefiorita 8
Warsaw 8
Amman 7
Ankara 7
Atlanta 7
Brasília 7
Cambridge 7
Cosenza 7
Denver 7
Montreal 7
Redmond 7
Stockholm 7
Thái Nguyên 7
Biên Hòa 6
Buffalo 6
Dhaka 6
Guarulhos 6
Manaus 6
Montevideo 6
Mumbai 6
Nuremberg 6
Phoenix 6
Tashkent 6
Baku 5
Belo Horizonte 5
Charlotte 5
Curitiba 5
Lahore 5
Livorno 5
Nairobi 5
Porto Alegre 5
Quanzhou 5
Salvador 5
Wuhan 5
Bắc Giang 4
Edmonton 4
Erbil 4
Totale 5.099
Nome #
First trimester combined test (FTCT) as a predictor of gestational diabetes mellitus 97
MicroRNA-1281 as a novel circulating biomarker in patients with diabetic retinopathy 94
A Partial Phenotype of adFNDI Related to the Signal Peptide c.55G>A Variant of the AVP Gene 89
A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components 87
A case of metastatic medullary thyroid carcinoma: early identification before surgery of a ret proto-oncogene somatic mutation in fine needle aspirate specimen 86
A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC 83
Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases 82
A novel mutation in the thyrotropin receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistence to TSH 80
diagnostics 79
A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin gene transcription 79
Obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance 79
A Phe 486 TSH receptor mutation in a autonomously functioning follicular carcinoma that was causing hyperthyroidism 77
A thyroid follicular cancer presenting as a hot nodule and hyperfunctioning because of an activating mutation of the TSH receptor 77
A modified quantitative EMSA and its application in the study of RNA-protein interactions 77
Insights into the World of MicroRNAs 76
A novel mutation in the Thyrotropin receptor gene causing loss of TSH binding but constitutive activation in a family with resistance to TSH 76
Cross-talk among HMGA1 and FoxO1 in control of nuclear insulin signaling 76
A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH 76
Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer 75
Barriers to postpartum glucose intolerance screening in an Italian population 74
Early Onset Acceleration of Fetal Growth in Gestational Diabetes Mellitus: Deciding About When and Whom to Screen for Preventing Fetal Macrosomia 74
A hyperfunctioning Hurtle cell thyroid carcinoma with a mutation in the thyrotropin receptor 74
A Val 677 activating mutation of the Thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis 74
Endocrines 71
HMGA1 is a novel candidate gene for myocardial infarction susceptibility 70
A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin 69
Appropriate timing of gestational diabetes mellitus diagnosis in medium- And low-risk women: Effectiveness of the Italian NHS recommendations in preventing fetal macrosomia 69
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis 68
Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy 68
A case of metastatic medullary thyroid carcinoma: Early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens 68
Malignancy Analyses of Thyroid Nodules in Patients Subjected to Surgery with Cytological- and Ultrasound-Based Risk Stratification Systems 68
A Val677 activating mutation of the thyrotropin receptor in a Hurtle cell thyroid carcinoma associated with thyrotossicosis 67
Does a polarization state exist for mast cells in cancer? 67
A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression 66
Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes Mellitus 66
Mutational Analysis of the AVP Gene in a Calabrian Family Affected by adFNDI 65
2-s2.0-85151325029 64
Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes 64
Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options 63
Activator protein-2 (AP-2) overexpression leading to increased insulin receptor (IR) expression is a critical event in human breast cancer 63
HMGA1 Deficiency—A Common Causal Link between Tau Pathology and Insulin Resistance? 62
Early Effects of a Hypocaloric, Mediterranean Diet on Laboratory Parameters in Obese Individuals 62
Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links 61
A nucleoprotein complex containing Sp1, C/EBPb, and HMGI(Y) controls human insulin receptor gene transcription 61
A new predictive tool for the early risk assessment of gestational diabetes mellitus 61
Long-term effectiveness of liraglutide for weight management and glycemic control in type 2 diabetes 61
HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance 61
Circulating Thrombospondin-1 and Endothelin-1 Levels Tend to Decline with Increasing Obesity Severity in Women: Evidence from a Pilot, Cross-Sectional Study 60
Insulin and osteocalcin: further evidence for a mutual cross-talk 60
Coexistence of Hashimoto’s Thyroiditis in Differentiated Thyroid Cancer: Post-Operative Monitoring of Anti-Thyroglobulin Antibodies and Assessment of Treatment Response 60
Antineoplastic effects of PPARg and thiazolidinedione-PPARg agonists 59
Gestational diabetes mellitus: an updated overview 58
Pòlimorfismo del gene HMGA1, metodo di individuazione e metodo di diagnosi genetica di insulino-resistenza e/o diabete mellito di tipo 2 58
Gestational diabetes and fetal overgrowth: time to rethink screening guidelines 58
The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1 58
A Val677 activating mutation of the thyrotropin receptor in a Hürtle cell thyroid carcinoma associated with thyrotoxicosis 57
CIRCULATING MIRNAS: A DIAGNOSTIC AND PROGNOSTIC TOOL IN TYPE 2 DIABETES MELLITUS (T2DM) 57
Innate immunity in cardiac myxomas and its pathological and clinical correlations 57
The penile duplex ultrasound: How and when to perform it? 57
Insulin receptor overexpression in human breast cancer: a new role for the activator protein-2 (ap-2) transcription factor 56
Insulin resistance and cancer: In search for a causal link 56
Predicting accelerated fetal growth in pregnancy: beyond maternal hyperglycemia – The role of prothymosin-α, inflammatory cytokines, and angiogenic factors 55
Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistance 55
Predicting the response to SGLT-2 inhibitors as add-on therapy to multiple day injection insulin with glycated albumin: a pilot study 54
Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes 54
Plasma or Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL): Which Is Better at Detecting Chronic Kidney Damage in Type 2 Diabetes? 54
Clinical Risk Factors and First Gestational 75g OGTT May Predict Recurrent and New-Onset Gestational Diabetes in Multiparous Women 53
Metformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the Question 53
Alterazioni del trasportatore dello iodio in patologia tiroidea 53
Genetica molecolare delle tireopatie 51
Transcriptional regulation of glucose metabolism: the emerging role of the HMGA1 chromatin factor 51
Functional Integrity of the Architectural Factor HMGA1 Is Required for Transactivation of the Insulin (Ins) Gene 50
A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism 50
Endocrines 49
Long-term diabetic complications in elderly patients with variable levels of HMGA1 expression 49
Secretome Analysis of Hypoxia-Induced 3T3-L1 Adipocytes Uncovers Novel Proteins Potentially Involved in Obesity 49
Functional variants of the HMGA1 gene decrease insulin receptor expression and confer a high risk for type 2 diabetes mellitus 48
Correlazione genotipo/fenotipo negli adenomi autonomi iperfunzionanti della tiroide con e senza mutazioni nella proteina Gs alfa o nel recettore del TSH 48
Recent advances in the molecular genetics of type 2 diabetes mellitus 48
Iodide symporter gene expression in normal and transformed rat thyroid cells 48
Biomarkers in Diabetes 47
From Euglycemia to Recent Onset of Type 2 Diabetes Mellitus: A Proof-of-Concept Study on Circulating microRNA Profiling Reveals Distinct, and Early microRNA Signatures 47
The insulin receptor: a new anticancer target for the peroxisome proliferator-activated receptor-g (PPARg) and thiazolidinedione-PPARg agonists 47
Postpartum Glucose Intolerance in Gestational Diabetes 47
Maternal Preconception Body Mass Index Overtakes Age as a Risk Factor for Gestational Diabetes Mellitus 46
The association between HMGA1 rs146052672 variant and Type 2 Diabetes: a trans-ethnic meta-analysis 46
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice 46
Overexpression of p75ntr in human seminoma: A new biomarker? 46
Functional Variants of the HMGAI Gene and Type 2 Diabetes Mellitus 45
Innate immunity in cardiac myxomas and its pathological and clinical correlations 45
Prothymosin-Alpha, a Novel and Sensitive Biomarker of the Inflammatory and Insulin-Resistant Statuses of Obese Individuals: A Pilot Study Involving Humans 44
A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription 44
A Nucleoprotein Complex Containing Sp1, C/EBPß, and HMGI-Y controls Human Insulin Receptor Gene Transcription 44
Comment on Li et al. HMGA1: A novel predisposing gene for acute myocardial infarction 44
Gestational Diabetes Mellitus: Screening and Outcomes in Southern Italian Pregnant Women 44
Cooperation between HMGA1 and HIF-1 contributes to hypoxia-induced VEGF and Visfatin gene expression in 3T3-L1 adipocytes 44
Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes 43
Current Opinion in Pharmacology 42
The cyclic AMP response element binding protein (CREB) is functionally reduced in human toxic thyroid adenomas 42
Genetic syndromes of extreme insulin resistance and diabetes mellitus due to defects in insulin receptor gene transcription 42
Totale 6.084
Categoria #
all - tutte 79.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022386 7 4 4 84 26 11 7 83 40 37 70 13
2022/20231.082 314 95 18 96 82 80 17 69 179 51 65 16
2023/2024540 67 73 68 29 35 160 20 9 15 20 9 35
2024/20252.013 256 165 139 94 97 222 54 40 287 73 219 367
2025/20264.205 212 486 553 701 403 213 507 300 431 289 98 12
Totale 8.645